RPRX logo

Royalty Pharma plc (RPRX) Depreciation & Amortization

Annual D&A:

$0.00$0.00(0.00%)
December 31, 2024

Summary

  • As of today, RPRX annual D&A is $0.00, unchanged on December 31, 2024.
  • During the last 3 years, RPRX annual D&A has fallen by -$23.00 million (-100.00%).
  • RPRX annual D&A is now -100.00% below its all-time high of $33.27 million, reached on December 31, 2017.

Performance

RPRX Depreciation & Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

Quarterly D&A:

N/A
June 30, 2025

Summary

  • RPRX quarterly D&A is not available.

Performance

RPRX Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherRPRXincome statement metrics

TTM D&A:

N/A
June 30, 2025

Summary

  • RPRX TTM D&A is not available.

Performance

RPRX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherRPRXincome statement metrics

RPRX Depreciation & Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year0.0%--
3Y3 Years-100.0%--
5Y5 Years-100.0%--

RPRX Depreciation & Amortization Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-100.0%at low
5Y5-Year-100.0%at low
All-TimeAll-Time-100.0%at low

RPRX Depreciation & Amortization History

DateAnnualQuarterlyTTM
Dec 2024
$0.00(0.0%)
-
-
Mar 2024
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2023
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2023
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2022
$5.67M(-75.3%)
$0.00(0.0%)
$5.67M(-50.5%)
Sep 2022
-
$0.00(0.0%)
$11.47M(-33.6%)
Jun 2022
-
$0.00(-100.0%)
$17.26M(-24.9%)
Mar 2022
-
$5.67M(-2.2%)
$23.00M(-0.0%)
Dec 2021
$23.00M
$5.80M(0.0%)
$23.00M(0.0%)
Sep 2021
-
$5.80M(+1.1%)
$23.00M(0.0%)
DateAnnualQuarterlyTTM
Jun 2021
-
$5.73M(+1.1%)
$23.00M(0.0%)
Mar 2021
-
$5.67M(-2.2%)
$23.00M(-0.3%)
Dec 2020
$23.06M(-3.6%)
$5.80M(0.0%)
$23.06M(0.0%)
Sep 2020
-
$5.80M(+1.1%)
$23.06M(0.0%)
Jun 2020
-
$5.73M(0.0%)
$23.06M(0.0%)
Mar 2020
-
$5.73M(-1.1%)
$23.06M(-3.6%)
Dec 2019
$23.92M(-28.1%)
$5.80M(0.0%)
$23.92M(+32.0%)
Sep 2019
-
$5.80M(+1.1%)
$18.13M(+47.0%)
Jun 2019
-
$5.73M(-13.1%)
$12.33M(+86.9%)
Mar 2019
-
$6.60M
$6.60M
Dec 2018
$33.27M(0.0%)
-
-
Dec 2017
$33.27M
-
-

FAQ

  • What is Royalty Pharma plc annual D&A?
  • What is the all-time high annual D&A for Royalty Pharma plc?
  • What is Royalty Pharma plc annual D&A year-on-year change?
  • What is the all-time high quarterly D&A for Royalty Pharma plc?
  • What is the all-time high TTM D&A for Royalty Pharma plc?

What is Royalty Pharma plc annual D&A?

The current annual D&A of RPRX is $0.00

What is the all-time high annual D&A for Royalty Pharma plc?

Royalty Pharma plc all-time high annual D&A is $33.27M

What is Royalty Pharma plc annual D&A year-on-year change?

Over the past year, RPRX annual D&A has changed by $0.00 (0.00%)

What is the all-time high quarterly D&A for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly D&A is $6.60M

What is the all-time high TTM D&A for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM D&A is $23.92M
On this page